{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:08:16Z","timestamp":1790611696039,"version":"4.1.0"},"reference-count":33,"publisher":"The Endocrine Society","issue":"9","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital Research Fund","doi-asserted-by":"publisher","award":["04-2017-3010"],"award-info":[{"award-number":["04-2017-3010"]}],"id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012261","name":"Ministry of Food and Drug Safety, South Korea","doi-asserted-by":"publisher","award":["22183MFDS431"],"award-info":[{"award-number":["22183MFDS431"]}],"id":[{"id":"10.13039\/501100012261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Emerging reports have raised concerns regarding the potential association between COVID-19 vaccination and thyroid dysfunction, specifically thyroiditis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study aimed to investigate the potential association between COVID-19 vaccination and thyroid diseases using data from a nationwide cohort of South Korea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study included 7 579 210 adult and 241 063 adolescent vaccine recipients. A self-controlled case series design was applied to estimate the incidence rate ratio (IRR) of thyroid disease during the 55-day postvaccination period (first and second dose) compared to the baseline period (nonexposure period) using conditional Poisson regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the adult population, IRRs for hyperthyroidism, hypothyroidism, subacute thyroiditis, and thyroid eye disease were 0.98 (95% CI, 0.89\u20131.09), 0.88 (95% CI, 0.84-0.93), 1.27 (95% CI, 0.94-1.72), and 0.68 (95% CI, 0.50-0.93) after the first vaccine dose and 0.96 (95% CI, 0.87-1.06), 0.96 (95% CI, 0.92-1.02), 1.32 (95% CI, 0.96-1.80), and 1.06 (95% CI, 0.81-1.38) after the second vaccine dose. While the risk of hyperthyroidism recurrence did not increase after vaccination, we observed an increased risk of hypothyroidism exacerbation. Subgroup analyses based on age, sex, and vaccine type revealed no significant differences in the incidence of thyroid diseases. In adolescents aged 12 to 17 years, no increase in the risk of thyroid disease was observed after vaccination.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This extensive, national self-controlled case series analysis found an increased risk of exacerbation of hypothyroidism following COVID-19 vaccination. However, no association was observed between COVID-19 vaccination and an increased risk of most other thyroid diseases. These findings contribute to increasing evidence supporting the safety of COVID-19 vaccination in relation to thyroid health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae858","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:39:11Z","timestamp":1733855951000},"page":"e3109-e3116","source":"Crossref","is-referenced-by-count":4,"title":["Effect of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2622-6553","authenticated-orcid":false,"given":"Sungho","family":"Bea","sequence":"first","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University , Suwon 16419 ,","place":["Republic of Korea"]},{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School , Boston, MA 02120 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2737-6759","authenticated-orcid":false,"given":"Hwa Young","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chung-ang University College of Medicine , Seoul 06973 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieun","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Biohealth Regulatory Science, Sungkyunkwan University , Suwon 16419 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Sungkyunkwan University , Suwon 16419 ,","place":["Republic of Korea"]},{"name":"Department of Biohealth Regulatory Science, Sungkyunkwan University , Suwon 16419 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-3830","authenticated-orcid":false,"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine , Seoul 03080 ,","place":["Republic of Korea"]},{"name":"Department of Internal Medicine, Seoul National University Hospital , Seoul 03080 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"issue":"2","key":"2025081215524632000_dgae858-B1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","article-title":"Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review","volume":"28","author":"Fiolet","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"10287","key":"2025081215524632000_dgae858-B2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"2025081215524632000_dgae858-B3","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s40618-022-01786-7","article-title":"Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence","volume":"45","author":"Jafarzadeh","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2025081215524632000_dgae858-B4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41574-023-00946-w","article-title":"Thyroid dysfunction in COVID-19","volume":"20","author":"Lui","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"2025081215524632000_dgae858-B5","doi-asserted-by":"crossref","first-page":"101759","DOI":"10.1016\/j.beem.2023.101759","article-title":"COVID-19 vaccination and thyroiditis","volume":"37","author":"Sendur","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"2025081215524632000_dgae858-B6","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/vaccines11101574","article-title":"Thyroid eye disease as initial manifestation of graves' disease following viral vector SARS-CoV-2 vaccine: report of a case and review of the literature","volume":"11","author":"Armeni","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"2025081215524632000_dgae858-B7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15605\/jafes.038.01.19","article-title":"New-onset thyroid eye disease after COVID-19 vaccination in a radioactive iodine-treated graves' disease patient: a case report and literature review","volume":"38","author":"Im Teoh","year":"2023","journal-title":"J ASEAN Fed Endocr Soc"},{"issue":"2","key":"2025081215524632000_dgae858-B8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/clinem\/dgad501","article-title":"Increased risk of thyroid eye disease following COVID-19 vaccination","volume":"109","author":"Muller","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025081215524632000_dgae858-B9","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1089\/thy.2022.0101","article-title":"Effect of inactivated SARS-CoV-2 vaccine on thyroid function and autoimmunity within 28 days after the second dose","volume":"32","author":"Li","year":"2022","journal-title":"Thyroid"},{"issue":"9","key":"2025081215524632000_dgae858-B10","doi-asserted-by":"crossref","first-page":"e3781","DOI":"10.1210\/clinem\/dgac355","article-title":"Effect of COVID-19 vaccines on thyroid function and autoimmunity and effect of thyroid autoimmunity on antibody response","volume":"107","author":"Lui","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025081215524632000_dgae858-B11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12916-022-02548-1","article-title":"Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients","volume":"20","author":"Wong","year":"2022","journal-title":"BMC Med"},{"issue":"5","key":"2025081215524632000_dgae858-B12","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1210\/clinem\/dgac684","article-title":"Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism","volume":"108","author":"Wong","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025081215524632000_dgae858-B13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/thy.2021.0684","article-title":"Safety of inactivated and mRNA COVID-19 vaccination among patients treated for hypothyroidism: a population-based cohort study","volume":"32","author":"Xiong","year":"2022","journal-title":"Thyroid"},{"issue":"38","key":"2025081215524632000_dgae858-B14","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1016\/j.vaccine.2023.07.053","article-title":"Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of graves' disease: an observational cohort study","volume":"41","author":"Xu","year":"2023","journal-title":"Vaccine"},{"issue":"9","key":"2025081215524632000_dgae858-B15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2022.12992","article-title":"Association between vaccination and acute myocardial infarction and ischemic stroke after COVID-19 infection","volume":"328","author":"Kim","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"2025081215524632000_dgae858-B16","first-page":"799","article-title":"Data resource profile: the national health information database of the national health insurance service in South Korea","volume":"46","author":"Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"10","key":"2025081215524632000_dgae858-B17","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"1","key":"2025081215524632000_dgae858-B18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3803\/EnM.2023.102","article-title":"Big data research in the field of endocrine diseases using the Korean national health information database","volume":"38","author":"Cho","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2025081215524632000_dgae858-B19","doi-asserted-by":"crossref","unstructured":"Bea S, Ahn HY, Woo J, et al \u00a0Data from: Supplemental Material for \u201cThe Impact of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients\u201d. Figshare. doi: 10.6084\/m9.figshare.27926526. Date of deposit 29 Nov 2024.","DOI":"10.1210\/clinem\/dgae858"},{"issue":"11","key":"2025081215524632000_dgae858-B20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/thy.2022.0363","article-title":"Incidence of subacute thyroiditis during the COVID-19 pandemic in South Korea using the national health insurance service database","volume":"32","author":"Ahn","year":"2022","journal-title":"Thyroid"},{"issue":"16","key":"2025081215524632000_dgae858-B21","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.3390\/jcm10163522","article-title":"The effects of previous thyroid disease on the susceptibility to, morbidity of, and mortality due to COVID-19: a nationwide cohort study in South Korea","volume":"10","author":"Kim","year":"2021","journal-title":"J Clin Med"},{"key":"2025081215524632000_dgae858-B22","doi-asserted-by":"crossref","first-page":"680647","DOI":"10.3389\/fendo.2021.680647","article-title":"Risk of all-cause mortality in levothyroxine-treated hypothyroid patients: a nationwide Korean cohort study","volume":"12","author":"Sohn","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025081215524632000_dgae858-B23","doi-asserted-by":"crossref","first-page":"900964","DOI":"10.3389\/fendo.2022.900964","article-title":"Thyroid inconveniences with vaccination against SARS-CoV-2: the size of the matter","volume":"13","author":"Caironi","year":"2022","journal-title":"A Systematic Review. Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025081215524632000_dgae858-B24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40618-021-01650-0","article-title":"Two further cases of graves' disease following SARS-cov-2 vaccination","volume":"45","author":"Zettinig","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"2025081215524632000_dgae858-B25","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1080\/21645515.2021.1947102","article-title":"Subacute thyroiditis following COVID-19 vaccination in a 67-year-old male patient: a case report","volume":"17","author":"Sahin Tekin","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025081215524632000_dgae858-B26","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"issue":"9","key":"2025081215524632000_dgae858-B27","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/thy.2021.0142","article-title":"Two cases of graves' disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants","volume":"31","author":"Vera-Lastra","year":"2021","journal-title":"Thyroid"},{"key":"2025081215524632000_dgae858-B28","doi-asserted-by":"crossref","first-page":"617089","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases","volume":"11","author":"Vojdani","year":"2020","journal-title":"Front Immunol"},{"key":"2025081215524632000_dgae858-B29","first-page":"150","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants and thyroid autoimmunity","volume":"7","author":"Watad","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"2025081215524632000_dgae858-B30","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1007\/s00431-023-05097-8","article-title":"Thyroid disturbances after COVID-19 and the effect of vaccination in children: a prospective tri-center registry analysis","volume":"182","author":"Herczeg","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"4","key":"2025081215524632000_dgae858-B31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3803\/EnM.2023.1684","article-title":"Prevalence, treatment Status, and comorbidities of hyperthyroidism in Korea from 2003 to 2018: a nationwide population study","volume":"38","author":"Ahn","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"8","key":"2025081215524632000_dgae858-B32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eprac.2023.05.005","article-title":"The incidence of graves' hyperthyroidism before and after COVID-19 messenger RNA vaccination","volume":"29","author":"Endo","year":"2023","journal-title":"Endocr Pract"},{"issue":"2","key":"2025081215524632000_dgae858-B33","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1210\/clinem\/dgad582","article-title":"Graves' disease following COVID-19 vaccination: a population-based, matched case-control study","volume":"109","author":"Gorshtein","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae858\/60999754\/dgae858.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e3109\/60999754\/dgae858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/9\/e3109\/60999754\/dgae858.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T19:52:58Z","timestamp":1755028378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/9\/e3109\/7919301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,12,9]]},"published-print":{"date-parts":[[2025,8,7]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae858","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2024,12,9]]}}}